GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Evaxion Biotech AS
Evaxion is a Danish biotech company using AI to develop vaccines and immunotherapies. Its stock price represents a venture bet on its technology platform. The chart reflects high volatility and dependence on clinical trial news.
Share prices of companies in the market segment - AI
Evaxion Biotech is a Danish company that uses artificial intelligence to discover and develop new immunotherapeutic drugs for cancer and infectious diseases. We've categorized it as an "AI" company. The chart below shows how the market views the use of AI in pharmaceuticals.
Broad Market Index - GURU.Markets
Evaxion Biotech is a Danish biotech company that uses artificial intelligence to develop personalized vaccines against cancer and infectious diseases. As a pioneer, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Evaxion's performance.
Change in the price of a company, segment, and market as a whole per day
EVAX - Daily change in the company's share price Evaxion Biotech AS
For Evaxion Biotech A/S, which uses AI to develop vaccines, daily volatility reflects sensitivity to clinical trial data. This metric is key for assessing risks at the intersection of biotech and artificial intelligence.
Daily change in the price of a set of shares in a market segment - AI
Evaxion Biotech A/S is a biotech company. This chart highlights the extreme volatility of the sector. Comparing it to EVAX, which uses AI to develop vaccines, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Evaxion is a Danish biotech company using artificial intelligence to develop vaccines and immunotherapies. The company is located at the intersection of two hot sectors—AI and biotech. This creates high volatility, which contributes to overall market dynamics.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Evaxion Biotech AS
Evaxion Biotech A/S's year-to-date performance is a story about the application of artificial intelligence in vaccine development. Its 12-month market cap depends entirely on progress in clinical trials of its personalized cancer vaccines. The success of its AI platform could fundamentally accelerate and reduce the cost of developing new immunotherapies.
Annual dynamics of market capitalization of the market segment - AI
Evaxion, as an early-stage biotech company, is a high-risk bet on science. Its performance is completely disconnected from the sector and depends on news about its AI-powered vaccine platform. Its stock price will reflect investors' speculative belief in its potential.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Evaxion Biotech is a company at the intersection of two hottest topics: artificial intelligence and biotechnology. Its shares are a pure bet on breakthrough technology. Its performance relative to the market demonstrates an exorbitant level of speculative expectations: any hint of research success triggers explosive growth, ignoring all external factors.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Evaxion Biotech AS
Evaxion is a biotech company using AI to develop vaccines. Being an early-stage company, its monthly valuation is based on the potential of its platform. News about progress in clinical trials and validation of its AI approach are key drivers.
Monthly dynamics of market capitalization of the market segment - AI
Evaxion Biotech uses artificial intelligence to develop personalized immunotherapeutics, including vaccines against cancer and infectious diseases. The chart below illustrates the overall dynamics of the AI and biotech sectors, where the confluence of these two fields promises to revolutionize medicine.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biotech stocks using AI to develop vaccines represent a dual bet on technology and science. The chart below shows the overall risk appetite. Is Evaxion Biotech moving at an elevated rate, reflecting the speculative nature of its industry?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Evaxion Biotech AS
Evaxion, a Danish biotech company using artificial intelligence to develop personalized immunotherapies, is extremely volatile. Its weekly stock price is a sharp reaction to the release of clinical trial data for its cancer vaccines and news about the progress of its AI platforms.
Weekly dynamics of market capitalization of the market segment - AI
Evaxion operates in the revolutionary immuno-oncology sector, where shared technological breakthroughs and regulatory decisions impact everyone. The success of one company can boost the entire segment. The chart will show whether EVAX is perceived by the market as a leader in this movement thanks to its AI approach or simply as part of it.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Evaxion Biotech A/S, as a biotech company, often ignores broader market trends. Its fate depends not on GDP or inflation, but on the results of clinical trials. The chart below clearly demonstrates how EVAX shares can rise or fall on their own news, while the overall market moves in a different direction.
Market capitalization of the company, segment and market as a whole
EVAX - Market capitalization of the company Evaxion Biotech AS
Evaxion Biotech's market cap is a bet on the use of AI to create vaccines. The company uses artificial intelligence to develop personalized vaccines for cancer and infectious diseases. Its valuation represents a speculative investor valuation of this cutting-edge, yet unproven, platform.
EVAX - Share of the company's market capitalization Evaxion Biotech AS within the market segment - AI
Evaxion Biotech is a Danish biotech company using artificial intelligence to develop personalized immunotherapeutics, particularly cancer vaccines. Its market share is based on its advanced AI platform. The chart shows how the market perceives its chances of achieving a breakthrough in personalized oncology.
Market capitalization of the market segment - AI
Evaxion Biotech is a Danish company using AI to develop vaccines against cancer and infectious diseases. The chart below shows the market capitalization of the AI sector in medicine. This is the valuation of one of the most advanced fields where algorithms help create personalized medicines.
Market capitalization of all companies included in a broad market index - GURU.Markets
Evaxion is a Danish biotech company that uses artificial intelligence to develop personalized vaccines against cancer and infectious diseases. Its market capitalization is a bet on this platform. The chart below shows the economic weight of the AI biotech sector.
Book value capitalization of the company, segment and market as a whole
EVAX - Book value capitalization of the company Evaxion Biotech AS
Evaxion Biotech is built on an artificial intelligence platform for vaccine development. The Danish company's book value reflects its investments in developing the PIONEER and EDEN AI platforms for identifying antigens for personalized vaccines against cancer and infectious diseases. The chart below shows how the company is building its unique computational and scientific foundation.
EVAX - Share of the company's book capitalization Evaxion Biotech AS within the market segment - AI
Evaxion Biotech, which uses AI to create vaccines, has key assets in the form of R&D laboratories and computing power. The S_BCap_Seg chart shows its share of scientific infrastructure, reflecting its focus on research.
Market segment balance sheet capitalization - AI
Evaxion Biotech uses artificial intelligence to develop immunotherapies. Its main asset is its computing platform and patents, not its laboratories. The chart will show how "lightweight" its model is, where the main value is created by algorithms, not physical experiments.
Book value of all companies included in the broad market index - GURU.Markets
Evaxion's book value is its artificial intelligence platform for vaccine development. The company's assets are not its factories, but its powerful computing resources and proprietary algorithms that predict immune targets. This is the technological foundation aimed at accelerating the development of personalized vaccines against cancer and other infections.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Evaxion Biotech AS
Evaxion Biotech uses artificial intelligence to develop vaccines and immunotherapies. Its book value is derived from R&D. Its market capitalization is a pure valuation of its AI platform and investors' belief that its technological approach will speed up and reduce the cost of developing new drugs.
Market to book capitalization ratio in a market segment - AI
Evaxion Biotech is a Danish company using AI to develop vaccines and immunotherapies. Its core value is its technology platform. The chart shows the significant market premium placed on its innovative approach to drug development compared to the value of its laboratories.
Market to book capitalization ratio for the market as a whole
Evaxion Biotech uses artificial intelligence to develop vaccines and immunotherapies. The company's value lies in its platform, which accelerates and reduces the cost of R&D. The chart illustrates how highly the market values AI technologies that have the potential to revolutionize the pharmaceutical industry.
Debts of the company, segment and market as a whole
EVAX - Company debts Evaxion Biotech AS
Evaxion Biotech, a company using AI to develop vaccines, funds its research through debt and equity. This chart shows how the company is raising funds to operate its AI platforms and conduct early clinical trials of personalized vaccines against cancer and infectious diseases.
Market segment debts - AI
Evaxion Biotech is a Danish biotech company using artificial intelligence to develop vaccines and immunotherapies. This cutting-edge approach requires significant and ongoing investment in R&D and computing power. This chart shows its financial position and reliance on equity capital to fund innovation.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Evaxion Biotech AS
Evaxion Biotech uses artificial intelligence to develop vaccines and immunotherapies. This chart shows how this cutting-edge company is funding its research. Raising debt for an AI biotech company is a bold move, reflecting high confidence in its platform, but also carries significant risk until clinical trial results are available.
Market segment debt to market segment book capitalization - AI
Evaxion Biotech uses artificial intelligence to develop vaccines and immunotherapies. This chart for the leading biotech company shows how much capital it is raising to fund breakthrough research. It provides context for evaluating the company's financial strategy at the intersection of AI and pharmaceuticals.
Debt to book value of all companies in the market
Evaxion Biotech uses artificial intelligence to develop immunotherapeutic drugs, including vaccines against cancer and infectious diseases. This chart, showing the market's debt-to-book value ratio, is important for assessing the investment climate. The market's willingness to finance breakthrough, yet capital-intensive, AI technologies in medicine will determine Evaxion's future.
P/E of the company, segment and market as a whole
P/E - Evaxion Biotech AS
Evaxion Biotech uses artificial intelligence to develop new vaccines and immunotherapies, primarily for cancer treatment. This chart reflects confidence in its technology platform. A high score indicates expectations that its AI approach will enable the development of personalized and more effective drugs faster than traditional methods.
P/E of the market segment - AI
Evaxion Biotech A/S is a biotech company. This chart shows the average price-to-earnings ratio (P/E) for the biotech sector. A company's P/E is higher than average, indicating that investors consider its AI platform for vaccine development particularly disruptive and are willing to pay a premium for its potential.
P/E of the market as a whole
Evaxion Biotech is a Danish company that uses an AI-powered platform to develop immunotherapeutic drugs, including vaccines for cancer and infectious diseases. This chart shows the risk appetite in biotech. The company's valuation is a bet that its AI platform can truly accelerate and reduce the cost of developing new drugs.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Evaxion Biotech AS
Evaxion Biotech is a Danish biotech company using artificial intelligence to develop cancer immunotherapies and vaccines. The chart reflects investor speculative expectations for its AI platform. Future revenue is entirely dependent on the success of clinical trials and proof of the effectiveness of this approach.
%20P%2FE%20Evaxion%20Biotech%20AS&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Evaxion-Biotech-AS&v=1772649658032 "Chart of the company's future (projected) P/E Evaxion Biotech AS")
Future (projected) P/E of the market segment - AI
Evaxion Biotech uses artificial intelligence to develop personalized immunotherapeutics for cancer and infectious diseases. This chart shows its future profitability expectations, providing insight into the market's value of its advanced vaccine platform.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-AI&v=1772649658052 "Future (projected) P/E graph of the market segment - AI")
Future (projected) P/E of the market as a whole
Evaxion Biotech is a Danish biotech company using artificial intelligence to develop vaccines and immunotherapies against cancer and infectious diseases. Its valuation is a bet on the success of its technology platform. It doesn't correlate with general market forecasts, but depends on scientific breakthroughs.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772649658072 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Evaxion Biotech AS
Evaxion Biotech A/S is a biotech company using artificial intelligence to develop personalized immunotherapeutic drugs, primarily for cancer treatment. Being in the clinical stage, it incurs significant R&D expenditures. This chart reflects its investment in a cutting-edge platform that has the potential to revolutionize vaccine and drug development.
Profit of companies in the market segment - AI
Evaxion Biotech A/S is a Danish company using artificial intelligence to develop immunotherapeutic drugs, specifically personalized cancer vaccines. This chart shows the profitability of the AI sector in medicine. While the company is still in the research stage, it is not profitable, but its breakthrough platform has the potential to radically change approaches to cancer treatment.
Overall market profit
Evaxion Biotech is a company using artificial intelligence to develop immunotherapeutic drugs, particularly cancer vaccines. Its value is determined by the potential of its technology platform and the success of its clinical trials. This chart illustrates general economic cycles, with Evaxion at the forefront of personalized medicine.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Evaxion Biotech AS
Evaxion Biotech is using artificial intelligence to develop next-generation immunotherapies for cancer and infectious diseases. This chart reflects analysts' long-term expectations for this cutting-edge technology platform. It demonstrates the market's belief that AI can accelerate and reduce the cost of developing personalized vaccines and drugs.
%20profit%20of%20the%20company%20Evaxion%20Biotech%20AS&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Evaxion-Biotech-AS&v=1772649658242 "Graph of future (projected) profit of the company Evaxion Biotech AS")
Future (predicted) profit of companies in the market segment - AI
Evaxion Biotech A/S is an artificial intelligence and immunology company developing personalized immunotherapies for cancer treatment. This chart shows profitability forecasts for the AI sector. It reflects expectations for the application of AI in the development of next-generation drugs, one of the most promising areas in biotech.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-AI&v=1772649658308 "Graph of future (predicted) profits of companies in a market segment - AI")
Future (predicted) profit of the market as a whole
Evaxion Biotech uses AI to develop vaccines and immunotherapies. For a leading biotech company, market profit forecasts are important as an indicator of the investment climate. Economic growth expectations, reflected in the graph, increase investor willingness to invest in risky but potentially breakthrough technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772649658372 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Evaxion Biotech AS
Evaxion Biotech A/S is a Danish biotech company using artificial intelligence to develop immunotherapies. Currently in the clinical stage, it has no revenue. Its valuation is based on investors' faith in its AI platform and the potential to create personalized vaccines.
P/S market segment - AI
Evaxion Biotech uses artificial intelligence to develop innovative immunotherapeutics, specifically personalized vaccines against cancer and infectious diseases. Their valuation is based on this cutting-edge platform. The chart shows the premium investors place on their AI-based approach to next-generation drug development.
P/S of the market as a whole
Evaxion Biotech uses artificial intelligence to develop vaccines and immunotherapies. The company has no commercial revenue, and its valuation reflects its belief in the potential of its technology platform. This chart, based on actual revenue, clearly demonstrates that Evaxion is betting on a future where AI will create medicines.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Evaxion Biotech AS
Evaxion Biotech is a company using artificial intelligence to develop immunotherapies, including personalized cancer vaccines and infectious disease treatments. This chart reflects investor expectations for future revenue from this cutting-edge platform, betting on the success of its AI-based approach to drug discovery.
%20P%2FS%20Evaxion%20Biotech%20AS&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Evaxion-Biotech-AS&v=1772649658540 "The graph of the company's future (projected) P/S Evaxion Biotech AS")
Future (projected) P/S of the market segment - AI
Evaxion Biotech A/S is a clinical-stage biotech company using artificial intelligence to develop novel immunotherapeutics for cancer and infectious diseases. This chart shows how the market views the future potential of its cutting-edge AI platform. It compares it to other AI and oncology companies, reflecting the market's belief in its technology.
%20P%2FS%20market%20segment%20graph%20-%20AI&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-AI&v=1772649658555 "Future (projected) P/S market segment graph - AI")
Future (projected) P/S of the market as a whole
Evaxion Biotech is a Danish company using artificial intelligence to develop next-generation immunotherapies for cancer and infectious diseases. This chart reflects general sales expectations, and EVAX is a shining example of how the synergy between AI and biotech is shaping the future of medicine and generating high investor expectations.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772649658595 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Evaxion Biotech AS
Evaxion Biotech A/S is a clinical-stage biotechnology company using artificial intelligence to develop personalized cancer immunotherapies and vaccines. The company currently has no commercial products, so sales revenue is not included in this chart. Revenue may arise from partnerships.
Sales of companies in the market segment - AI
Evaxion Biotech is an artificial intelligence company specializing in the development of immunotherapeutic drugs. At this stage, its revenue, if any, may come from partnerships. This chart allows investors to evaluate the financial support supporting the potential of its AI platform.
Overall market sales
Evaxion Biotech uses artificial intelligence to develop immunotherapies. Like other AI biotech companies, its success depends on the effectiveness of its platform and the results of clinical trials. This overall market performance graph has no bearing on scientific and technological progress, which is Evaxion's sole driver.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Evaxion Biotech AS
Evaxion Biotech is a company using artificial intelligence to develop immunotherapies for cancer and infectious diseases. Its revenue forecast is dependent on the success of clinical trials. This chart reflects analysts' speculative expectations for its technology platform and vaccine portfolio.
%20sales%20of%20the%20company%20Evaxion%20Biotech%20AS&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Evaxion-Biotech-AS&v=1772649658692 "Schedule of future (projected) sales of the company Evaxion Biotech AS")
Future (projected) sales of companies in the market segment - AI
Evaxion Biotech uses artificial intelligence to develop immunotherapeutic drugs. This chart displays projected revenues for the entire AI pharmaceutical sector. It provides insight into how rapidly analysts expect this cutting-edge market to grow, which is critical to the future commercial success of Evaxion's innovative platform.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-AI&v=1772649658713 "Schedule of future (projected) sales of companies in the market segment - AI")
Future (projected) sales of the market as a whole
Evaxion Biotech is a Danish biotech company using artificial intelligence to develop immunotherapies for cancer and infectious diseases. Its future depends on the success of its AI platform and clinical trials. This graph of overall market expectations reflects the investment climate, which is important for funding cutting-edge and capital-intensive R&D projects.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772649658734 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Evaxion Biotech AS
Evaxion Biotech is an artificial intelligence company using its platform to develop new immunotherapeutic drugs. This chart reflects the financial implications of this cutting-edge research. Future profitability depends entirely on the success of its AI-powered clinical programs.
Market segment marginality - AI
Evaxion Biotech uses AI-powered platforms to identify and develop new immunotherapies for cancer and infectious diseases. This chart shows the average profitability in the biotech and AI sector. It helps assess the commercial advantage Evaxion's advanced technological approach to creating personalized vaccines could bring.
Market marginality as a whole
Evaxion Biotech A/S is a Danish company using artificial intelligence to develop immunotherapeutic drugs, including cancer vaccines. This is at the cutting edge of science. This overall profitability chart has nothing to do with Evaxion's valuation, which is a bet that its AI platform will be able to create effective drugs of the future.
Employees in the company, segment and market as a whole
Number of employees in the company Evaxion Biotech AS
Evaxion Biotech is a company using artificial intelligence to develop immunotherapy. Its team consists of scientists and AI specialists working at the intersection of biotechnology and IT. The growth in this chart reflects the progress of its unique platform and the advancement of candidates into clinical trials.
Share of the company's employees Evaxion Biotech AS within the market segment - AI
Evaxion Biotech A/S is an artificial intelligence (AI) and immunology company developing personalized immunotherapies for cancer treatment. This chart highlights its cutting-edge technological approach. It reflects the proportion of AI specialists, bioinformaticians, and immunologists working at the intersection of technology and medicine to create cancer vaccines within Evaxion.
Number of employees in the market segment - AI
Evaxion Biotech A/S is a Danish company using artificial intelligence to develop immunotherapies for cancer and infectious diseases. This chart illustrates employment in the AI sector in medicine. The rapid growth reflects the revolution in drug discovery, where AI is helping to quickly identify new targets and create personalized vaccines.
Number of employees in the market as a whole
Evaxion Biotech A/S is a Danish company using artificial intelligence to develop vaccines and immunotherapies. The combination of AI and biotechnology is at the cutting edge of modern science. This graph illustrates overall employment, where such innovative companies are creating demand for unique specialists at the intersection of IT and biology.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Evaxion Biotech AS (EVAX)
Evaxion Biotech is using AI to develop vaccines. It's at the cutting edge of science. This chart illustrates the enormous value the market sees in this synergy between AI and biotech. The astronomical market capitalization per employee reflects the valuation of this unique platform, which promises to accelerate and reduce the cost of creating new vaccines.
%20of%20the%20company%20Evaxion%20Biotech%20AS%20(EVAX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Evaxion-Biotech-AS-EVAX&v=1772649658991 "Chart of market capitalization per employee (in thousands of dollars) of the company Evaxion Biotech AS (EVAX)")
Market capitalization per employee (in thousands of dollars) in the market segment - AI
Evaxion Biotech uses artificial intelligence to develop vaccines and immunotherapies. In this cutting-edge field, its market capitalization per employee reflects investors' faith in its revolutionary platform. This very high figure reflects the enormous potential the market sees in AI's ability to accelerate the development of new drugs.
%20by%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-AI&v=1772649659039 "Market capitalization per employee (in thousands of dollars) by market segment - AI")
Market capitalization per employee (in thousands of dollars) for the overall market
Evaxion Biotech uses artificial intelligence to develop new immunotherapeutic drugs, particularly cancer vaccines. This is at the absolute cutting edge of science. This chart reflects the enormous investor anticipation of its team of scientists and AI specialists' ability to create a revolutionary new treatment.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772649659058 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Evaxion Biotech AS (EVAX)
Evaxion Biotech is a biotech company using its own AI platform to develop vaccines and immunotherapies (for oncology and infectious diseases). It's an R&D company. This chart, in negative territory, shows how much capital is being burned per scientist and data scientist in this high-tech race.
%20Chart%20Evaxion%20Biotech%20AS%20(EVAX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Evaxion-Biotech-AS-EVAX&v=1772649659062 "Company Profit Per Employee (in thousands of dollars) Chart Evaxion Biotech AS (EVAX)")
Profit per employee (in thousands of dollars) in the market segment - AI
Evaxion Biotech A/S is an artificial intelligence (AI) company specializing in immunotherapy drug development. This chart highlights the potential value of their AI platform. It demonstrates how using advanced drug discovery algorithms can enable a small team of scientists to create innovative treatments with enormous commercial potential.
%20in%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-AI&v=1772649659074 "Chart of profit per employee (in thousands of dollars) in the market segment - AI")
Profit per employee (in thousands of dollars) for the market as a whole
Evaxion Biotech A/S is a Danish biotech company using AI to develop cancer immunotherapies and vaccines. It's a hybrid of AI and biotech. This chart reflects the "cost" of R&D. It shows how much the company invests in its AI platforms and research team to create the next generation of drugs, which requires significant per-employee costs.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772649659079 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Evaxion Biotech AS (EVAX)
Evaxion Biotech is a biotech company using AI to develop vaccines. At the clinical trial stage, this graph does not reflect commercial activity. It represents scientific potential. A successful launch of one of the products will lead to explosive growth in this metric.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Evaxion-Biotech-AS-EVAX&v=1772649659099 "Sales chart per company employee Evaxion Biotech AS (EVAX)")
Sales per employee in the market segment - AI
Evaxion Biotech (EVAX) is a Danish biotech company using AI platforms (PIONEER, EDEN) to develop personalized vaccines against cancer and infectious diseases. This chart shows the average revenue per employee in the segment. For Evaxion, which is in the R&D stage, comparing it to this benchmark (zero) highlights their focus on AI development rather than sales.
Sales per employee for the market as a whole
Evaxion Biotech (EVAX) is a biotech company using AI to develop vaccines (including cancer vaccines). It's a clinical-stage R&D company with no revenue. This metric is irrelevant. Their entire value lies in the potential of their AI platform to create new drugs.
Short shares by company, segment and market as a whole
Shares shorted by company Evaxion Biotech AS (EVAX)
Evaxion Biotech is a Danish biotech company using AI to develop vaccines against cancer and infectious diseases. This represents the intersection of two hyped themes. This chart shows that investors are skeptical of their AI platform. The bears are betting that their developments will fail to demonstrate efficacy in clinical trials, which is typical for this sector.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Evaxion-Biotech-AS-EVAX&v=1772649659221 "Short Shares Chart for the Company Evaxion Biotech AS (EVAX)")
Shares shorted by market segment - AI
Evaxion Biotech (EVAX) is a Danish biotech using AI to develop personalized cancer vaccines. It's a "double hype": AI and oncology. This chart shows the pessimism in the sector. The growing short position in the sector is a bet that the technology won't work. Investors doubt that AI can truly predict which vaccine will help a patient and expect clinical trials to fail.
Shares shorted by the overall market
Evaxion (EVAX) is a biotech company using AI to develop drugs. It's a speculative "hype" stock. When this general fear indicator rises, investors flee the hype. They fear that unprofitable AI biotech companies like EVAX won't survive a recession, so they sell them off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Evaxion Biotech AS (EVAX)
Evaxion Biotech uses AI to develop vaccines and immunotherapies. It's a fusion of two of the hottest sectors—AI and biotech. This chart shows the feverish anticipation. It could instantly overheat to extreme levels on any news that their AI platform has discovered a promising new molecule.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Evaxion-Biotech-AS-EVAX&v=1772649659308 "RSI 14 indicator chart for the company's stock Evaxion Biotech AS (EVAX)")
RSI 14 Market Segment - AI
Evaxion Biotech is a Danish biotech company that uses AI platforms (PIONEER, EDEN) to discover and develop new immunotherapies for cancer and infectious diseases. This chart reflects the overall sentiment in the AI and biotech sectors. It helps assess whether the hype surrounding this segment is overheated amid the general excitement.
RSI 14 for the overall market
Evaxion (EVAX) is a biotech R&D company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast EVAX (Evaxion Biotech AS)
Evaxion Biotech (EVAX) is a Danish company using AI to develop immunotherapeutic drugs and vaccines, primarily for cancer treatment. This chart shows the average 12-month forecast. It reflects analysts' confidence in its AI platforms (PIONEER, EDEN) and the potential of its clinical candidates.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-EVAX-Evaxion-Biotech-AS&v=1772649659380 "A chart showing analyst consensus forecasts for the expected stock price. EVAX (Evaxion Biotech AS)")
The difference between the consensus estimate and the actual stock price EVAX (Evaxion Biotech AS)
Evaxion Biotech is a Danish AI company. It uses its AI platform to discover and develop next-generation immunotherapies and vaccines against cancer and infections. This chart measures the gap between the current share price and the consensus target price. It highlights the enormous, yet risky, potential analysts see in their AI R&D platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-EVAX-Evaxion-Biotech-AS&v=1772649659425 "A chart showing the difference between the consensus forecast and the actual stock price. EVAX (Evaxion Biotech AS)")
Analyst consensus forecast for stock prices by market segment - AI
Evaxion Biotech is a "TechBio" company using AI platforms to "design" vaccines against cancer and infectious diseases. This R&D company operates at the intersection of AI and immunology. This chart reflects analysts' general expectations across the AI sector. It shows whether experts believe AI can accelerate drug development.
Analysts' consensus forecast for the overall market share price
Evaxion is a Danish biotech company that uses AI (PIONEER and EDEN platforms) to discover and develop vaccines against cancer and infectious diseases. This chart shows the overall risk appetite in the market. For Evaxion, which operates at the intersection of two hot but speculative sectors (AI and biotech), overall market optimism (the rising chart) is critical for funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Evaxion Biotech AS
Evaxion is a next-generation biotech company. They're not looking for cures in vitro; they're using AI platforms (PIONEER, EDEN) to predict and design new vaccines against cancer (immuno-oncology) and bacteria. This chart is a clear indicator of their R&D confidence. It doesn't reflect revenue, but rather a speculative valuation of their computing platform and their progress in clinical trials.
AKIMA Market Segment Index - AI
Evaxion Biotech (EVAX) is a Danish biotech company using artificial intelligence to develop next-generation vaccines. Their AI platforms (PIONEER, EDEN) identify targets for personalized vaccines against cancer and other infections. The chart shows the segment average, helping investors assess how this cutting-edge AI approach compares to the industry average.
The AKIM Index for the overall market
Evaxion Biotech is a Danish company using artificial intelligence (AI-Immunology) to develop personalized vaccines against cancer and other infections. This chart, which reflects the market average, provides context. It helps assess how this cutting-edge AI biotech company stacks up against overall macroeconomic trends.
